# Aligos Therapeutics, Inc.: Form 8-K, filed Oct 18, 2023

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2023-10-18
- Accepted by EDGAR: Oct 18, 2023, 08:45 ET
- Period: 2023-10-16
- Accession: 0001193125-23-258115
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/d562095d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/d562095d8k.htm

Filed Oct 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-258115. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.